Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome

Patients with metabolically healthy obesity (MHO) do not present the cluster of metabolic abnormalities that define the metabolic syndrome (MetS). Whether MHO is associated with lower impairment of vasoreactivity than the MetS is unknown. For this purpose, forearm blood flow (FBF) responses were mea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Physiol Endocrinol Metab
Main Authors: Schinzari, Francesca, Iantorno, Micaela, Campia, Umberto, Mores, Nadia, Rovella, Valentina, Tesauro, Manfredi, Di Daniele, Nicola, Cardillo, Carmine
Formato: Artigo
Idioma:Inglês
Publicado: American Physiological Society 2015
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4628941/
https://ncbi.nlm.nih.gov/pubmed/26374766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00278.2015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares